Article
[Clinical management of familial platelet disorder with associated myeloid malignancies: at the crossroads of hematology and clinical genetics].
[Rinsho ketsueki] The Japanese journal of clinical hematology - 1 Jan 2026
Watanabe Mizuki
Abstract excerpt
With the widespread adoption of genomic testing, germline predisposition syndromes such as RUNX1-familial platelet disorder with associated myeloid malignancy (FPD-MM) are increasingly encountered in routine hematological practice. FPD-MM is driven by RUNX1 haploinsufficiency, which initially manifests as quantitative and qualitative platelet abnormalities. Over time, this constitutional defect promotes the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
